메뉴 건너뛰기




Volumn 75, Issue 7, 2008, Pages 739-743

Current trends in the management of Beta Thalassemia

Author keywords

Beta Thalassemia; Iron chelation; Iron overload

Indexed keywords

ASCORBIC ACID; CALCIUM; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; DIGOXIN; GLIBENCLAMIDE; IRON CHELATING AGENT; LEVOTHYROXINE; METFORMIN; VITAMIN D;

EID: 50249128697     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-008-0140-4     Document Type: Conference Paper
Times cited : (27)

References (25)
  • 1
    • 29744463847 scopus 로고    scopus 로고
    • Longitudinal study of survival and causes of death in patients with thalassemia major in Greece
    • V. Ladis G. Chouliaras H. Berdousi E. Kanavakis C. Kattamis 2005 Longitudinal study of survival and causes of death in patients with thalassemia major in Greece Ann N Y Acad Sci 1054 445 450
    • (2005) Ann N Y Acad Sci , vol.1054 , pp. 445-450
    • Ladis, V.1    Chouliaras, G.2    Berdousi, H.3    Kanavakis, E.4    Kattamis, C.5
  • 4
    • 33644874106 scopus 로고    scopus 로고
    • Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassemia
    • Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassemia. Cochrane Database Syst Rev 2005 19: CD004450.
    • (2005) Cochrane Database Syst Rev , vol.19
    • Roberts, D.J.1    Rees, D.2    Howard, J.3    Hyde, C.4    Alderson, P.5    Brunskill, S.6
  • 5
    • 50249119276 scopus 로고    scopus 로고
    • Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major
    • Dec 22; [Epub ahead of print]
    • Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR et al. Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major. Blood 2005 Dec 22; [Epub ahead of print]
    • (2005) Blood
    • Borgna-Pignatti, C.1    Cappellini, M.D.2    De Stefano, P.3    Del Vecchio, G.C.4    Forni, G.L.5    Gamberini, M.R.6
  • 6
    • 27644547811 scopus 로고    scopus 로고
    • A Phase II Study with ICL670 (Exjade®), a Once-Daily Oral Iron Chelator, in Patients with Various Transfusion-Dependent Anemias and Iron Overload
    • J. Porter E. Vichinsky C. Rose A. Piga N. Olivieri N. Gattermann 2004 A Phase II Study with ICL670 (Exjade®), a Once-Daily Oral Iron Chelator, in Patients with Various Transfusion-Dependent Anemias and Iron Overload Blood 104 872A 872A
    • (2004) Blood , vol.104
    • Porter, J.1    Vichinsky, E.2    Rose, C.3    Piga, A.4    Olivieri, N.5    Gattermann, N.6
  • 7
    • 33646426524 scopus 로고    scopus 로고
    • A randomized, controlled phase II trial in sickle cell disease patients with chronic iron overload demonstrates that the once-daily oral iron chelator deferasirox (Exjade ((R)) ICL670) is well tolerated and reduces iron
    • E. Vichinsky R. Fischer E. Fung O. Onyekwere J. Porter P. Swerdlow 2005 A randomized, controlled phase II trial in sickle cell disease patients with chronic iron overload demonstrates that the once-daily oral iron chelator deferasirox (Exjade ((R)) ICL670) is well tolerated and reduces iron Blood 106 95A 95A
    • (2005) Blood , vol.106
    • Vichinsky, E.1    Fischer, R.2    Fung, E.3    Onyekwere, O.4    Porter, J.5    Swerdlow, P.6
  • 8
    • 1542352269 scopus 로고    scopus 로고
    • Phase II study of ICL670, an oral chelator, in adult thalassaemia patients with transfusional iron overload: Efficacy, safety, pharmaco kinetics (PK) and pharmacodynamics (PD) after 18 months of therapy
    • A. Piga R. Galanello M.D. Cappellini G.L. Forni G. Lupo J.M. Ford 2003 Phase II study of ICL670, an oral chelator, in adult thalassaemia patients with transfusional iron overload: Efficacy, safety, pharmaco kinetics (PK) and pharmacodynamics (PD) after 18 months of therapy Blood 102 121A 121A
    • (2003) Blood , vol.102
    • Piga, A.1    Galanello, R.2    Cappellini, M.D.3    Forni, G.L.4    Lupo, G.5    Ford, J.M.6
  • 9
    • 27744518242 scopus 로고    scopus 로고
    • Once-daily treatment with the oral iron chelator ICL670 (Exjade (R): Results of a phase II study in pediatric patients with beta thalassernia major
    • A. Piga R. Galanello M.L. Foschini A. Zappu E. Bordone F. Longo 2004 Once-daily treatment with the oral iron chelator ICL670 (Exjade (R): Results of a phase II study in pediatric patients with beta thalassernia major Blood 104 983A 983A
    • (2004) Blood , vol.104
    • Piga, A.1    Galanello, R.2    Foschini, M.L.3    Zappu, A.4    Bordone, E.5    Longo, F.6
  • 10
    • 33646414765 scopus 로고    scopus 로고
    • A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with ta-thalassemia
    • Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L et al. A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with ta-thalassemia. Blood 2006; 107: 3455-3462.
    • (2006) Blood , vol.107 , pp. 3455-3462
    • Cappellini, M.D.1    Cohen, A.2    Piga, A.3    Bejaoui, M.4    Perrotta, S.5    Agaoglu, L.6
  • 11
    • 27144560152 scopus 로고    scopus 로고
    • Combined therapy with deferiprone and desferrioxamine in thalassemia major
    • R. Origa P. Bina A. Agus G. Crobu E. Defraia C. Dessý 2005 Combined therapy with deferiprone and desferrioxamine in thalassemia major Haematologica 90 1309 1314
    • (2005) Haematologica , vol.90 , pp. 1309-1314
    • Origa, R.1    Bina, P.2    Agus, A.3    Crobu, G.4    Defraia, E.5    Dessý, C.6
  • 12
    • 0037125595 scopus 로고    scopus 로고
    • Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta thalassemia
    • L.J. Anderson B. Wonke E. Prescott S. Holden J.M. Walker D.J. Pennell 2002 Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta thalassemia Lancet 360 516 520
    • (2002) Lancet , vol.360 , pp. 516-520
    • Anderson, L.J.1    Wonke, B.2    Prescott, E.3    Holden, S.4    Walker, J.M.5    Pennell, D.J.6
  • 13
  • 14
    • 12544260252 scopus 로고    scopus 로고
    • Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: A multicenter study by the Thalassaemia International Federation (TIF)
    • V. De Sanctis A. Eleftheriou C. Malaventura 2004 Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF) Pediatr Endocrinol Rev 2 249 255
    • (2004) Pediatr Endocrinol Rev , vol.2 , pp. 249-255
    • De Sanctis, V.1    Eleftheriou, A.2    Malaventura, C.3
  • 15
    • 0242439285 scopus 로고    scopus 로고
    • Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment
    • K.H. Wu F.J. Tsai C.T. Peng 2003 Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment Ann Hematol 82 540 637
    • (2003) Ann Hematol , vol.82 , pp. 540-637
    • Wu, K.H.1    Tsai, F.J.2    Peng, C.T.3
  • 16
    • 0035344276 scopus 로고    scopus 로고
    • Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic Patients
    • J. P. S. Chern K. H. Lin M. Y. Lu D. T. Lin K. S. Lin J.D. Chen 2001 Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic Patients Diabetes Care 24 850 854
    • (2001) Diabetes Care , vol.24 , pp. 850-854
    • Chern, J.P.S.1    Lin, K.H.2    Lu, M.Y.3    Lin, D.T.4    Lin, K.S.5    Chen, J.D.6
  • 19
    • 0020418846 scopus 로고
    • Family reactions and their management in a parents group with beta-thalassemia
    • J. Tsiantis D. Xypolita-Tsantili S. Papadakou-Lagoyianni 1982 Family reactions and their management in a parents group with beta-thalassemia Arch Dis Child 57 860 863
    • (1982) Arch Dis Child , vol.57 , pp. 860-863
    • Tsiantis, J.1    Xypolita-Tsantili, D.2    Papadakou-Lagoyianni, S.3
  • 20
    • 34748898486 scopus 로고    scopus 로고
    • Psychological problems and quality of life in children with thalassemia
    • D. Shaligram S.C. Girimaji S.K. Chaturvedi 2007 Psychological problems and quality of life in children with thalassemia Indian J Pediatr 74 727 730
    • (2007) Indian J Pediatr , vol.74 , pp. 727-730
    • Shaligram, D.1    Girimaji, S.C.2    Chaturvedi, S.K.3
  • 21
    • 0034482701 scopus 로고    scopus 로고
    • At term pregnancies in transfusion-dependent beta-thalassemic women
    • C. Pafumi M. Farina G. Pernicone 2000 At term pregnancies in transfusion-dependent beta-thalassemic women Clin Exp Obstet Gynecol 27 185 187
    • (2000) Clin Exp Obstet Gynecol , vol.27 , pp. 185-187
    • Pafumi, C.1    Farina, M.2    Pernicone, G.3
  • 23
    • 0032437614 scopus 로고    scopus 로고
    • Fertility in thalassemia: The Greek experience
    • Suppl3
    • M. Karagiorga-Lagana 1998 Fertility in thalassemia: the Greek experience J Pediatr Endocrinol Metab 11 Suppl3 945 951
    • (1998) J Pediatr Endocrinol Metab , vol.11 , pp. 945-951
    • Karagiorga-Lagana, M.1
  • 24
    • 50249143666 scopus 로고    scopus 로고
    • Successful pregnancy in thalassemia major women in the Thalassemia Clinical Research Network
    • M.J. Cunningham E.A. Macklin G. Muraca E.J. Neufeld 2004 Successful pregnancy in thalassemia major women in the Thalassemia Clinical Research Network Pediatr Res 55 294
    • (2004) Pediatr Res , vol.55 , pp. 294
    • Cunningham, M.J.1    MacKlin, E.A.2    Muraca, G.3    Neufeld, E.J.4
  • 25
    • 0033846355 scopus 로고    scopus 로고
    • Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload
    • R. Chatterjee M. Katz 2000 Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload Clin Endocrinol 53 33 42
    • (2000) Clin Endocrinol , vol.53 , pp. 33-42
    • Chatterjee, R.1    Katz, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.